Scinovex
article Open AccessTop 10% cited

Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8<sup>+</sup> T cell activation and cytolysis

European Journal of Immunology · 2003 · Vol. 33(11) · pp. 3117–3126
Nancy RodigTimothy A. RyanJessica A. AllenHong PangNir GrabieTatyana ChernovaEdward GreenfieldSpencer C. LiangArlene H. SharpeAndrew H. LichtmanGordon J. Freeman

Abstract

Interactions between CD8+ T cells and endothelial cells are important in both protective and pathologic immune responses. Endothelial cells regulate the recruitment of CD8+ T cells into tissues, and the activation of CD8+ T cells by antigen presentation and costimulatory signals. PD-L1 and PD-L2 are recently described B7-family molecules which bind to PD-1 on activated lymphocytes and down-regulate T cell activation. We found that PD-L1 is expressed on interferon-gamma stimulated cultured human and mouse endothelial cells, while PD-L2 was found on stimulated human but not mouse endothelial cells. Expression was further up-regulated by TNF-alpha. Antibody blockade of endothelial cell PD-L1 and PD-L2 enhanced endothelial cell costimulation of PHA-activated human CD8+ T cells. Antibody blockade of mouse endothelial cell PD-L1 enhanced both IFN-gamma secretion and cytolytic activity of CD8+ T cells in response to endothelial cell antigen presentation. These results show that IFN-gamma activated endothelial cells can inhibit T cell activation via expression of the immunoinhibitory PD-L1 and PD-L2 molecules. Endothelial expression of PD-ligands would allow activation and extravasation of T cells without excessive vessel damage. Our findings highlight a potentially important pathway by which endothelial cells down-regulate CD8+ T cell-mediated immune responses.

T-cell and B-cell ImmunologyAtherosclerosis and Cardiovascular DiseasesCancer Immunotherapy and BiomarkersBiologyCytotoxic T cellCell biologyEndothelial stem cellCD8T cellInterleukin 21CytolysisAntigen-presenting cellImmune system

MeSH terms

AnimalsAntigen-Presenting CellsBlood ProteinsEndothelium, VascularHumansMembrane GlycoproteinsPeptidesAntigens, CDB7-1 AntigenCD8-Positive T-LymphocytesIntercellular Signaling Peptides and ProteinsMiceB7-H1 AntigenProgrammed Cell Death 1 Ligand 2 Protein

Funding

  • National Institutes of Health
Citations
473
FWCI
4.10
field-weighted impact
References
44
Percentile
95%
vs. same field & year
Citations per year
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Annual Review of Immunology · 2008 · 5,272 citations
Role of the PD-1 Pathway in the Immune Response
American Journal of Transplantation · 2012 · 427 citations
THE B7 FAMILY REVISITED
Annual Review of Immunology · 2005 · 2,279 citations
The PD‐1 pathway in tolerance and autoimmunity
Immunological Reviews · 2010 · 2,263 citations
The diverse functions of the PD1 inhibitory pathway
Nature reviews. Immunology · 2017 · 1,942 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.